Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human ACPP Anticorps:
anti-Mouse (Murine) ACPP Anticorps:
anti-Rat (Rattus) ACPP Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Polyclonal ACPP Primary Antibody pour IHC, IHC (p) - ABIN4347795
Kato, Nicholson, Neiman, Rantalainen, Holmes, Barrett, Uhlén, Nilsson, Spector, Schwenk: Variance decomposition of protein profiles from antibody arrays using a longitudinal twin model. dans Proteome science 2011
Show all 2 Pubmed References
Human Polyclonal ACPP Primary Antibody pour IHC (p), WB - ABIN513082
Cotella, Hernandez-Enriquez, Duan, Wu, Gazula, Brown, Kaczmarek, Sesti: An evolutionarily conserved mode of modulation of Shaw-like K? channels. dans FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2013
Human Polyclonal ACPP Primary Antibody pour ELISA, IHC - ABIN4347792
Quintero, Araujo, Pulkka, Wirkkala, Herrala, Eskelinen, Jokitalo, Hellström, Tuominen, Hirvikoski, Vihko: Prostatic acid phosphatase is not a prostate specific target. dans Cancer research 2007
Human Polyclonal ACPP Primary Antibody pour ELISA, IHC - ABIN4347794
Münch, Rücker, Ständker, Adermann, Goffinet, Schindler, Wildum, Chinnadurai, Rajan, Specht, Giménez-Gallego, Sánchez, Fowler, Koulov, Kelly, Mothes, Grivel, Margolis, Keppler, Forssmann, Kirchhoff: Semen-derived amyloid fibrils drastically enhance HIV infection. dans Cell 2007
Human Polyclonal ACPP Primary Antibody pour ELISA, IHC - ABIN570986
Nousiainen, Quintero, Myöhänen, Voikar, Mijatovic, Segerstråle, Herrala, Kulesskaya, Pulkka, Kivinummi, Abo-Ramadan, Taira, Piepponen, Rauvala, Vihko: Mice deficient in transmembrane prostatic acid phosphatase display increased GABAergic transmission and neurological alterations. dans PLoS ONE 2014
Enhanced TDPase and TMPase activities may contribute to the reduction of TDP level in AD patients. The results imply that an imbalance of phosphorylation-dephosphorylation related to thiamine and glucose metabolism may be a potential target for AD prevention and therapy.
Thirteen single nucleotide polymorphism (SNPs) in acid phosphatase prostate (ACPP) were suggested as candidate causal alleles that underlie ACPP regulation and expression.
we have measured the intramolecular diffusion of the full length and 8-residue deletion peptides at two different pHs (Montrer PCBD1 Anticorps) and found a correlation with fibrillization lag (Montrer STMN1 Anticorps) time. These results can be explained by a simple kinetic model of the early stages of aggregation in which oligomerization is controlled by the rate of peptide reconfiguration.
Prostatic acid phosphatase delays prostate cancer cell growth in G1 phase of the cell cycle.
Studies suggest that understanding of prostatic acid phosphatase function and regulation of expression will have a significant impact on understanding prostate cancer (PCa (Montrer FLVCR1 Anticorps)) progression and therapy.
Certain factors identified within semen, termed semen-derived enhancers of virus infection (SEVI), fragments of prostatic acid phosphatase, have been shown to significantly enhance HIV-1 infectivity.
ACPP increases significantly in epithelial cells of ovarian carcinoma, which indicates that it may be a candidate biomarker for diagnosis of epithelia-derived ovarian cancer in women.
Data indicate that hypoxia regulates prostatic acid phosphatase (PAP) through hypoxia-inducible factor 2 alpha (Montrer EPAS1 Anticorps) (HIF2alpha (Montrer EPAS1 Anticorps)) and from stimulated A2B (Montrer ADORA2B Anticorps) adenosine receptors.
GCNT1 (Montrer GCNT1 Anticorps) is over-expressed in prostate cancer and is associated with higher levels of core 2 O-sLe(x) in PSA (Montrer PLAG1 Anticorps), PAP (Montrer REG3A Anticorps) and MUC1 (Montrer MUC1 Anticorps) proteins.
Data indicate that prostate acid phosphatase-based peptide vaccine PAP (Montrer REG3A Anticorps)-114-128 peptide appears to be a relevant for the treatment of prostate cancer.
PAP (Montrer ASAP1 Anticorps)-immunoreactivity was present in type I and one of type III taste cells of taste buds. Thus, it is suggested that PAP (Montrer ASAP1 Anticorps) might be a responsible ectoenzyme for metabolism of extracellular nucleotides, being involved in the regulation of taste signaling in taste buds.
These findings demonstrate that PAP (Montrer ASAP1 Anticorps) secreted by PCa (Montrer ENPP1 Anticorps) cells in OB bone metastases increases osteoprotegerin (Montrer TNFRSF11B Anticorps) and plays a critical role in the vicious cross talk between cancer and bone cells.
functional PAP (Montrer ASAP1 Anticorps)(thorn) neurons are essential for the analgesic effect, which is mediated by NGF (Montrer NGFB Anticorps)-trkA (Montrer NTRK1 Anticorps) signaling.
TMPAP is involved in the control of GABAergic tone in the brain also through exocytosis, and that PAP (Montrer ASAP1 Anticorps) deficiency produces a distinct neurological phenotype.
In male mouse saliva (Montrer RAG1AP1 Anticorps) prostatic acid phosphatase regulates salivation.
Data indicate that prostate acid phosphatase-based peptide vaccine PAP (Montrer ASAP1 Anticorps)-114-128 peptide appears to be a relevant for the treatment of prostate cancer.
this PAP (Montrer ASAP1 Anticorps)-/- mouse model shows that TMPAP is required for the normal function of prostate in mice, and its deficiency leads to prostate adenocarcinoma.
Both prostatic acid phosphatase and ecto-5'-nucleotidase generate adenosine in the dorsal spinal cord.
Prostatic acid phosphatase is required for the antinociceptive effects of thiamine and benfotiamine.
Experiments indicate that PAP (Montrer ASAP1 Anticorps) and NT5E (Montrer NT5E Anticorps) are the main ectonucleotidases that generate adenosine in nociceptive circuits and indicate these enzymes transform pulsatile or sustained nucleotide release into an inhibitory adenosinergic signal.
The obtained N-terminal amino-acid sequence of boar PTAP showed 92% identity with the N-terminal amino-acid sequence of human PAP (Montrer PDAP1 Anticorps). The determined sequence of a 354 bp nucleotide fragment showed 90% identity with the corresponding sequence of human PAP (Montrer PDAP1 Anticorps).
This gene encodes an enzyme that catalyzes the conversion of orthophosphoric monoester to alcohol and orthophosphate. It is synthesized under androgen regulation and is secreted by the epithelial cells of the prostate gland. An alternatively spliced transcript variant encoding a longer isoform has been found for this gene. This isoform contains a transmembrane domain and is localized in the plasma membrane-endosomal-lysosomal pathway.
, prostatic acid phosphatase
, prostatic acid phosphotase
, thiamine monophosphatase
, fluoride-resistant acid phosphatase
, lysosomal acid phosphatase
, prostatic acid phosphatase (rPAP)
, acid phosphatase, prostate
, tyrosine acid phosphatase
, prostatic acid phosphatase-like
, testicular acid phosphatase homolog